Eris Lifesciences

Eris Lifesciences Adds Akhil Awasthi as Independent Director

Eris Lifesciences appoints Mr. Akhil Awasthi as Additional Director (Non-Executive, Independent) for five years, effective Sep 26, 2026. Mr. Awasthi brings 30+ years of experience in private equity, healthcare, investments, and corporate governance. Source: BSE

Eris COO Krishnakumar Vaidyanathan Resigns, Effective Sep 2026

Eris Lifesciences' COO Krishnakumar Vaidyanathan resigns, effective Sep 30, 2026. Resignation accepted; he steps down to pursue external professional opportunities. Source: MarketScreener India

Eris Lifesciences Updates Loan Details, Urges Fact Verification

Eris Lifesciences clarifies loan value in official disclosures, correcting reported inaccuracies. Investors advised to verify facts from company exchanges before decisions. Source: ScoutQuest

Eris Lifesciences Plans Sept 10 Analyst Meet; No UPSI

Eris Lifesciences informs BSE/NSE of analyst meeting on Sept 10, 2026. Meeting with Bank of India Mutual Fund; no UPSI to be discussed. Source: BSE

Eris Lifesciences Reappoints Sujesh Vasudevan as Independent Director for 5 Years

Eris Lifesciences Board reappoints Mr. Sujesh Vasudevan as Independent Director for 5 years starting July 2027. Company schedules its 20th AGM on September 25, 2026; meeting details shared per SEBI regulations. Source: BSE

Eris Lifesciences: Company Plans Meeting With Analysts And Investors On August 27 At 10:30 AM

Eris Lifesciences to Meet HBM Partners on Aug 27, 2026

Eris Lifesciences to meet HBM Partners AG on Aug 27, 2026 in person at 10:30 AM IST. Meeting will follow SEBI norms; no unpublished price-sensitive information will be shared. Source: BSE